As contemporary surgical practice continues to evolve, patients who undergo surgical lung volume reduction (LVRS) for ...

Guillain-Barré Syndrome (GBS) is a rare neurological disorder where the immune system attacks nerves. Learn about symptoms, ...

Guillain Barré Syndrome overview: symptoms, causes, treatment, and potential complications, including recent outbreak in Pune ...

Guillain-Barré Syndrome (GBS) is a rare yet potentially life-threatening neurological condition in which the immune system ...

India's first Guillain-Barre Syndrome death reported in Maharashtra—what’s causing the outbreak, who’s at risk. Read on to ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. ("Atara" or "the Company") for ...

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr ...

The FDA has said it cannot approve tabelecleucel to treat patients 2 years of age and older who have EBV-positive PTLD and have received at least 1 prior therapy.

Maharashtra's health department has reported over 100 cases of Guillain-Barré Syndrome (GBS) in Pune, with one suspected ...

The FDA didn't approve the therapy in EBV-positive post-transplant lymphoproliferative disease due to findings at a third-party manufacturing facility.